![]()
35
| 4 | 2005
Klinisk Biokemi i Norden
Referenser
1. Myocardial infarction redefined - A consen-
sus document of The Joint European Society
of Cardiology/American College of Cardiology
Committee for the Redefinition of Myocardial
Infarction. Eur Heart J 2000;21:1502-13.
3. Katrukha AG, Bereznikova AV, Esakova TV,
Pettersson K, Lövgren T, Severina ME, et al.
Troponin I is released in bloodstream of patients
with acute myocardial infarction not in free form
but as complex. Clin Chem 1997;43:1379-85.
7. Katrukha AG, Bereznikova AV, Filatov VL, Esakova
TV, Kolosova OV, Pettersson K, et al. Degradation
of cardiac troponin I: implication for reliable
immunodetection. Clin Chem 1998;44:2433-40.
12. Katrukha A, Bereznikova A, Filatov V, Esakova
T. Biochemical factors influencing measurement
of cardiac troponin I in serum. Clin Chem Lab
Med 1999;37:1091-5.
16. Panteghini M, Gerhardt W, Apple FS, Dati F,
Ravkilde J, Wu AH. Quality specifications for
cardiac troponin assays. Clin Chem Lab Med
2001;39:175-9.
34. Bohner J, von Pape KW, Hannes W, Stegmann T.
False-negative immunoassay results for cardiac
troponin I probably due to circulating troponin I
autoantibodies. Clin Chem 1996;42:2046.
35. Eriksson S, Junikka M, Laitinen P, Majamaa-
Voltti K, Alfthan H, Pettersson K. Negative
interference in cardiac troponin I immunoassays
from a frequently occurring serum and plasma
component. Clin Chem 2003;49:1095-104.
36. Eriksson S, Hellman J, Pettersson K.
Autoantibodies against cardiac troponins. N
Engl J Med 2005;352:98-100.
37. Eriksson S, Halenius H, Pulkki K, Hellman J,
Pettersson K. Negative interference in cardiac
troponin I immunoassays by circulating tropo-
nin autoantibodies. Clin Chem 2005;51:839-47.
38. Eriksson S, Junikka M, Pettersson K. An inter-
fering component in cardiac troponin I immu-
noassays - Its nature and inhibiting effect on the
binding of antibodies against different epitopes.
Clin Biochem 2004;37:472-80.
39. Eriksson S, Ilva T, Becker C, Lund J, Porela P,
Pulkki K, et al. Comparison of cardiac troponin
I immunoassays variably affected by circulating
autoantibodies. Clin Chem 2005;51:848-55.
40. Ilva T, Eriksson S, Lund J, Porela P, Mustonen
H, Pettersson K, et al. Improved early risk strati-
fication and diagnosis of myocardial infarction,
using a novel troponin I assay concept. Eur J
Clin Invest 2005;35:112-6.
42. Tate JR, Heathcote D, Rayfield J, Hickman PE.
The lack of standardization of cardiac troponin I
assay systems. Clin Chim Acta 1999;284:141-9.
45. Apple FS, Wu AH, Jaffe AS. European Society of
Cardiology and American College of Cardiology
guidelines for redefinition of myocardial infarc-
tion: how to use existing assays clinically and
for clinical trials. Am Heart J 2002;144:981-6.
53. Ottani F, Galvani M, Nicolini FA, Ferrini D,
Pozzati A, Di Pasquale G, et al. Elevated cardiac
troponin levels predict the risk of adverse outco-
me in patients with acute coronary syndromes.
Am Heart J 2000;140:917-27.
Foto: Ingunn Torsteinsdottir
